Literature DB >> 11725729

Women's decision-making determinants in choosing uterine artery embolization for symptomatic fibroids.

N S Nevadunsky1, G A Bachmann, J Nosher, T Yu.   

Abstract

OBJECTIVE: To determine what symptoms of leiomyomata uteri prompted women to seek uterine artery embolization (UAE) and what factors were most frequently cited in the decision making leading to choosing UAE over other treatments. STUDY
DESIGN: Eighty-four consecutive women with symptomatic leiomyoma presenting for UAE completed a questionnaire that inquired about their pelvic symptoms and the issues that were important in their decision to request UAE. All subjects previously had been told that they were surgical candidates.
RESULTS: Pelvic symptoms that the 84 women most frequently noted were bleeding (n = 61), anemia (41), pelvic pain (29), frequent urination (24) and pelvic pressure (21). The majority of women (78) reported significant worry about their health from the fibroids, and (72) reported that the symptoms caused daily discomfort. Although the majority of women wanted a treatment that would give permanent relief of symptoms and thought UAE would do this, other factors frequently cited in the decision making included quality-of-life reasons, such as the desire to avoid adverse effects of other treatments (76), anticipated prolonged postoperative recovery from surgery (70) and avoiding surgery (66). Many women considered the uterus an important female organ, believed that the uterus was a source of femininity (33), stated that the uterus was necessary to maintain self-image (49) and reported that the uterus was necessary to maintain sexual image (49).
CONCLUSION: In this cohort of women with symptomatic leiomyomas, treatment preferences did not interfere with the current lifestyle. In addition, the uterus was considered a source of femininity and sexuality. It is not clear whether women requesting UAE differ from women requesting surgical intervention in terms of how they assess the importance of the uterus, but these data suggest that many women still consider the uterus an important aspect of their femininity and that those seeking nonsurgical options should be thoroughly counseled about uterine function and how it relates to sexuality.

Entities:  

Mesh:

Year:  2001        PMID: 11725729

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  5 in total

1.  Volumetric MR-guided high-intensity focused ultrasound versus uterine artery embolisation for treatment of symptomatic uterine fibroids: comparison of symptom improvement and reintervention rates.

Authors:  Marlijne E Ikink; Robbert J Nijenhuis; Helena M Verkooijen; Marianne J Voogt; Paul J H M Reuwer; Albert J Smeets; Paul N M Lohle; Maurice A A J van den Bosch
Journal:  Eur Radiol       Date:  2014-08-13       Impact factor: 5.315

2.  Midterm outcome of radiofrequency thermal ablation for symptomatic uterine myomas.

Authors:  Fabio Ghezzi; Antonella Cromi; Valentino Bergamini; Stefano Scarperi; Pierfrancesco Bolis; Massimo Franchi
Journal:  Surg Endosc       Date:  2007-05-19       Impact factor: 4.584

3.  The benefit of myomectomy in women aged 40 years and above: Experience in an urban teaching hospital in Nigeria.

Authors:  Jesse Y Obed; Babagana Bako; Saidu Kadas; Joshua D Usman; Abubakar A Kullima; Joel Y Moruppa
Journal:  Niger Med J       Date:  2011-07

4.  Sexuality and body image after uterine artery embolization and hysterectomy in the treatment of uterine fibroids: a randomized comparison.

Authors:  Wouter J K Hehenkamp; Nicole A Volkers; Wouter Bartholomeus; Sjoerd de Blok; Erwin Birnie; Jim A Reekers; Willem M Ankum
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Sep-Oct       Impact factor: 2.740

5.  Identifying What Matters to Hysterectomy Patients: Postsurgery Perceptions, Beliefs, and Experiences.

Authors:  Andrew S Bossick; Roopina Sangha; Heather Olden; Gwen L Alexander; Ganesa Wegienka
Journal:  J Patient Cent Res Rev       Date:  2018-04-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.